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Abstract
Motivation: Recently, it has become feasible to generate large-scale,
multi-tissue gene expression data, where expression profiles are obtained
from multiple tissues or organs sampled from dozens to hundreds of indi-
viduals. When traditional clustering methods are applied to this type of
data, important information is lost, because they either require all tissues
to be analyzed independently, ignoring dependencies and similarities be-
tween tissues, or to merge tissues in a single, monolithic dataset, ignoring
individual characteristics of tissues.
Results: We developed a Bayesian model-based multi-tissue clustering
algorithm, revamp, which can incorporate prior information on physiolog-
ical tissue similarity, and which results in a set of clusters, each consist-
ing of a core set of genes conserved across tissues as well as differential
sets of genes specific to one or more subsets of tissues. Using data from
seven vascular and metabolic tissues from over 100 individuals in the
STockholm Atherosclerosis Gene Expression (STAGE) study, we demon-
strate that multi-tissue clusters inferred by revamp are more enriched for
tissue-dependent protein-protein interactions compared to alternative ap-
proaches. We further demonstrate that revamp results in easily inter-
pretable multi-tissue gene expression associations to key coronary artery
disease processes and clinical phenotypes in the STAGE individuals.
Availability: Revamp is implemented in the Lemon-Tree software, avail-
able at https://github.com/eb00/lemon-tree.
Contact: tom.michoel@roslin.ed.ac.uk
1 Introduction
Clustering gene expression data into groups of genes sharing the same
expression profile across multiple conditions remains one of the most im-
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portant methods for reducing the dimensionality and complexity of large-
scale microarray and RNA-sequencing datasets [13, 4, 54]. Coexpres-
sion clusters group functionally related genes together, and reveal how
diverse biological processes and pathways respond to the underlying per-
turbation of the biological system of interest. Traditionally, clustering
is performed by collecting data from multiple experimental treatments
[15], time points [50], cell or tissue types [20], or genetically diverse indi-
viduals [23] in a single data matrix from which meaningful patterns are
extracted using any of a whole range of statistical and algorithmic ap-
proaches. More recently, it has become feasible to probe systems along
two or more of these dimensions simultaneously. In particular, we are in-
terested in multi-tissue data, where gene expression profiles are obtained
from multiple tissues or organs sampled from dozens to hundreds of indi-
viduals [34, 28, 25, 21, 26, 17, 19, 27]. These data can potentially reveal
the similarity and differences in (co)expression between tissues as well as
the tissue-specific variation in (co)expression across individuals.
However, when traditional clustering methods are applied to this type
of data, important information is lost. For instance, if each tissue-specific
sub-dataset is clustered independently, the resulting sets of clusters will
rarely align, and to compare clusters across tissues, one will be faced
with the general problem of determining cluster preservation statistics
[35]. If instead the data are concatenated ‘horizontally’ in a single gene-
by-sample matrix, a common set of clusters will be found, but these will
be biased heavily towards house-keeping processes that are coexpressed
in all tissues. A potentially more promising approach is to concatenate
data ‘vertically’ in a tissue-gene-by-individual matrix, where the entities
being clustered are ‘tissue-genes’, the tissue-specific expression profiles of
genes [14, 52]. However, in studies with a large number of tissues, the
number of individuals with available data in all tissues is typically very
small, i.e. a large number of samples will have to be discarded to obtain
a tissue-gene-by-individual matrix without missing data.
Dedicated clustering algorithms for multi-tissue expression data are
scarce, and mostly based on using the higher-order generalized singular
value decomposition or related matrix decomposition techniques, to iden-
tify common and differential clusters across multiple conditions [43, 36,
55]. While algebraic methods are attractive for their relative efficiency
and simplicity, they lack the flexibility, robustness and statistical sound-
ness of Bayesian model-based clustering methods, which model the data
as a whole using mixtures of probability distributions [18, 48, 30]. Model-
based clustering is particularly attractive for multi-tissue data, because it
would allow, at least in principle, to account for different noise levels and
sample sizes in different tissues and to incorporate prior information on
the relative similarity between certain (groups of) tissues based on their
known physiological function. Here we present a novel statistical frame-
work and inference algorithm for model-based clustering of multi-tissue
gene expression data, which can incorporate prior information on tissue
similarity, and which results in a set of clusters, each consisting of a core
set of genes conserved across tissues as well as differential sets of genes
specific to one or more subsets of tissues.
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2 Approach
In model-based clustering, a partitioning of genes into non-overlapping
clusters parametrizes a probabilistic model from which the expression data
is assumed to have been generated, typically in the form of a mixture dis-
tribution where each cluster corresponds to one mixture component. Us-
ing Bayes’ theorem, this can be recast as a probability distribution on the
set of all possible clusterings parameterized by the expression data, from
which maximum-likelihood solutions can be obtained using expectation-
maximization or Gibbs sampling [18, 39, 30].
Our approach to clustering multi-tissue data combines ideas from ex-
isting ordinary (“single-tissue”) [44, 32] and multi-species [46] model-
based clustering methods. We use the generative model of [44] and [32]
to obtain the posterior probability for a (single-tissue) clustering given a
(single-tisse) dataset. From [46] we use the idea that a multi-tissue clus-
tering consists of a set of linked clusters, where cluster k in one tissue
corresponds to cluster k in any other tissue, and each cluster k contains
a core set of genes, belonging to cluster k in all tissues, and a differen-
tial set of tissue-specific genes, belonging to cluster k in one or more, but
not all, tissues. Like [46], we assume that the data from one tissue can
influence the clustering in another tissue, albeit via a simpler mechanism
as we do not aim to reconstruct any phylogenetic histories among tissues.
In brief, we assume that the posterior probability distribution of cluster-
ings in tissue t is given by its ordinary single-tissue distribution given the
expression data for tissue t, multiplied by a tempered distribution for ob-
serving that same clustering given the expression data for all other tissues
t′ 6= t. The degree of tempering determines the degree of influence of one
tissue on another, and can be used to model known prior relationships be-
tween tissues. For instance, we expect a priori that coexpression clusters
will be more similar between vascular tissues, than between vascular and
metabolic tissues.
3 Methods
3.1 Statistical model for single-tissue clustering
Our method is based on previous model-based clustering algorithms appli-
cable to single-tissue data [44, 32]. In brief, for an expression data matrix
X ∈ RG×N for G genes and N samples, a clustering C is defined as a par-
tition of the genes into K non-overlapping sets Ck. We assume that the
data points for the genes in each cluster and each sample are normally
distributed around an unknown mean and unknown variance/precision.
Given a clustering C and a set of means and precisions (µkn, τkn) for each
cluster k and sample n, we obtain a distribution on expression data ma-
trices as
p
(
X | C, {µkn, τkn}
)
=
K∏
k=1
N∏
n=1
∏
g∈Ck
p(xgn | µkn, τkn).
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Assuming a uniform prior on the clusterings C and independent normal-
gamma priors on the normal distribution parameters, we can use Bayes’
rule to find the marginal posterior probability of observing a clustering C
given data X, upto a normalization constant:
P (C | X) ∝
K∏
k=1
N∏
n=1
∫∫
p(µ, τ)
∏
g∈Ck
p(xgn | µ, τ) dµdτ. (1)
Note that we use a capital ‘P ’ to indicate that this is a discrete distribu-
tion. p(µ, τ) = p(µ | τ)p(τ) is the normal-gamma prior, with
p(µ | τ) = (λ0τ
2pi
)1/2
e−
λ0τ
2
(µ−µ0)2 , p(τ) =
βα00
Γ(α0)
τα0−1e−β0τ ,
α0, β0, λ0 > 0 and −∞ < µ0 < ∞ being the parameters of the normal-
gamma prior distribution. We use the values α0 = β0 = λ0 = 0.1 and µ0 =
0.0, resulting in a non-informative prior. The double integral in (1) can be
solved exactly in terms of the sufficient statistics T
(α)
kl =
∑
i∈Ck
∑N
n=1 x
α
in
(α = 0, 1, 2) for each cluster, see [32] for details.
For computational purposes, the decomposition of eq. (1) into a prod-
uct of independent factors, one for each cluster and sample, is important.
We write the log-likelihood or Bayesian score accordingly as:
S(C) = logP (C | X) =
K∑
k=1
N∑
n=1
Skn. (2)
3.2 Statistical model for multi-tissue clustering
Next, we assume that expression data X = [X1 ∈ RG×N1 , . . . ,XT ∈
RG×NT ] is available for G genes in T tissues, with Nt samples in each
tissue t ∈ {1, . . . , T}. We define a multi-tissue clustering as a collection of
single-tissue clusterings C = {C1, . . . , CT }, and assume that the probability
of observing C given data X is given by
P (C | X) = P (C1, . . . , CT | X1, . . . ,XT )
=
1
Z
T∏
t=1
{
P
(Ct | Xt) ∏
t′ 6=t
P
(Ct | Xt′)λt,t′}, (3)
where Z is a normalization constant which we henceforth will ignore,
each factor P
(Ct | X′t) is a single-tissue posterior probability distribution
defined in eq. (1), and λt,t′ ∈ [0, 1] is a set of hyper-parameters; for
notational convenience we define λt,t = 1.
Note that P
(Ct | Xt′) is a discrete distribution measuring how well
clustering Ct is supported by data Xt′ . Raising a discrete distribution
to a power less than 1 has the effect of making the distribution more
uniform. Hence in eq. (3), we are asking that clustering Ct is supported
predominantly by data Xt from its own tissue, but also, albeit to a lesser
extent depending on the values of λt,t′ , by data from the other tissues.
Optimizing eq. (3) across all multi-tissue clusterings is challenging.
A considerable simplification is obtained if we constrain the problem to
4
multi-tissue clusterings with the same number of clusters K in each tissue.
Denoting by It the set of samples/individuals in tissue t and by N =∑T
t=1Nt the total number of samples, the decomposition in eq. (2) allows
to write:
logP (C | X) =
T∑
t=1
T∑
t′=1
λt,t′ logP (Ct | Xt′)
=
T∑
t=1
T∑
t′=1
λt,t′
K∑
k=1
∑
n∈It′
S(t)kn
=
T∑
t=1
K∑
k=1
N∑
n=1
γ(t)n S(t)kn , (4)
where we used λt,t = 1, defined γ
(t)
n ≡ λt,t(n), with t(n) the tissue to
which sample n belongs, and wrote S(t)kn to denote the Bayesian score of
clustering Ct with respect to sample n.
Two extremal choices for the hyper-parameters are of interest. If
λt,t′ = 1 for all t, t
′, then the Bayesian score
S(t) =
K∑
k=1
N∑
n=1
γ(t)n S(t)kn (5)
is the same for each tissue t and identical to eq. (2) for the concatenated
data matrix X = [X1, . . . ,XT ]. Hence this is equivalent to clustering the
entire dataset as if it came from a single-tissue (termed ‘horizontal’ data
concatenation in the Introduction). If λt,t′ = 0 for t
′ 6= t, then eq. (3)
decomposes as a product of independent single-tissue factors. This is
equivalent to clustering each tissue sub-dataset independently.
3.3 Optimization algorithm
To find a local maximum of the Bayesian score in eq. (4), the following
heuristic, greedy optimization algorithm was used:
1. Data standardization: Using appropriately normalized gene ex-
pression data, each gene is standardized to have mean zero and stan-
dard deviation one on the concatenated data X.
2. Determine the number of clusters: K-means clustering is run
on the concatenated data with the number of clusters ranging from
2 to 100. The optimal number K is selected by visual inspection of
an elbow plot.
3. Initialize multi-tissue clustering: Starting from the k-means
clustering output at the selected number of clusters, genes are re-
assigned until a local optimum is reached for the single-tissue score
eq. (2) on the concatenated data X. All Ct are initialized by this
clustering.
4. Optimize multi-tissue clustering: For each tissue t, optimize
Ct by finding a local maximum for the Bayesian score eq. (5) using
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single-gene reassignments; only gene reassignments improving the
score by a minimum threshold  are considered.
Note that even in the case λt,t′ = 0 for t
′ 6= t, which removes all tis-
sue dependencies in the Bayesian score (4), this algorithm still results
in a multi-tissue clustering with linked clusters, due to each tissue being
initialized by the same clustering and converging to a local optimum.
3.4 Implementation
The statistical model and optimization algorithm have been implemented
in java, as an extension of the ‘task’ revamp in the Lemon-Tree software,
available at https://github.com/eb00/lemon-tree.
3.5 The STockholm Atherosclerosis Gene Expres-
sion study
In the STockholm Atherosclerosis Gene Expression (STAGE) study, 612
tissue samples from 121 individuals were obtained during coronary artery
bypass grafting surgery from the atherosclerotic arterial wall (AAW, n =
73), internal mammary artery (IMA, n = 88), liver (n = 87), skeletal
muscle (SM, n = 89), subcutaneous fat (SF, n = 72) and visceral fat (VF,
n = 98) of well-characterized CAD patients; fasting whole blood (WB)
was obtained for isolation of DNA (n = 109) and RNA (n = 105) and bio-
chemical analyses. RNA samples were used for gene expression profiling
with a custom Affymetrix array (HuRSTA- 2a520709) [28, 17, 52]. To en-
able comparison across tissues, all samples were jointly normalized using
Affymetrix Power Tools (v1.4.2). 4956 genes with variance greater than 1
across all 612 samples were selected for further analysis, and subsequently
standardized to have mean zero and standard deviation one, again across
all 612 samples.
3.6 Methods for comparison
We ran three multi-tissue clustering methods:
• Revamp with reassignment threshold  =0.005 and prior tissue simi-
larities λt,t′ = ρ
α
t,t′ , where ρt,t′ is the average correlation coefficient
between samples from tissue t and t′ measured in the same individual
and α = 0.25.
• Revamp with reassignment threshold  =0.005 and prior tissue simi-
larities λt,t′ = 0.
• An alternative method, which treats the expression profile of each
gene g in each tissue t as a separate (gene, tissue) variable and clus-
ters the resulting (gene,tissue)-by-individual expression matrix using
the single-tissue clustering algorithm (Section 3.1). This results in
a single set of clusters, which are disentangled into a set of linked
clusters, by assigning gene g to cluster m in tissue t whenever (g, t)
belongs to original cluster m. This method was called “vertical data
concatenation” before, and relies on having expression data from
6
multiple tissues in the same individual. In STAGE, 21 individuals
had data in all 7 tissues.
• Single-tissue clustering on the entire dataset of 612 samples (called
“horizontal data concatenation” before). This results in an identical
clustering across all tissues. It is not a true multi-tissue cluster-
ing method, but is used as an overall benchmark to determine the
relevance of a multi-tissue approach.
3.7 Validation data
To evaluate the biological relevance of each multi-tissue clustering method,
we used the following approach:
• We performed GSEA using first the GOSlim ontology, that gives
a broad overview of the ontology content without the detail of the
specific fine-grained terms (http://www.geneontology.org/page/go-
slim-and-subset-guide), and after on GO terms (http://www.geneontology.org/
page/download-ontology).
• We assigned sets of “regulators” to each of the modules considering
as candidate regulators the tissue-specific sets of genes with signifi-
cant eQTLs (2464 AAW, 3209 IMA, 4491 liver, 2534 SM, 2373 SF,
2994 VF and 5691 WB genes) [17].
• We obtained human tissue protein–protein interaction (PPI) net-
works from [6]. Specifically, we used TissueNet v2 networks con-
sisting of curated experimentally detected PPIs between proteins
expressed in Genotype-Tissue Expression dataset tissues ‘Artery –
Aorta’, ‘Liver’, ‘Muscle – Skeletal’, ‘Adipose – Subcutaneous’, ‘Adi-
pose – Visceral (Omentum)’ and ‘Whole Blood’, available for down-
load at http://netbio.bgu.ac.il/labwebsite/?q=tissuenet2-download.
3.8 Validation methods
We tested for GO functional enrichment using the task go annotation
in the Lemon-Tree software, and task regulatorswas used to identify
gene “regulators” using a probabilistic scoring, taking into account the
profile of the candidate regulator and how well it matches the profiles of
co-expressed genes [31].
To test for enrichment of known PPIs in a given clustering, we calcu-
lated the fold-change enrichment as
FC =
Number of co-clustered gene pairs with PPI
Total number of PPI
Total number of co-clustered gene pairs
Total number of gene pairs
All clustering methods were run on the seven available STAGE tissues,
and the results for six tissues were used for validation (IMA did not have
a matching tissue in the TissueNet database). To evaluate the clustering
of a particular tissue, we used all PPIs for that tissue. To evaluate the
core gene set of a cluster (for cluster m, the set of genes belonging to m
in all tissues), we used the set of PPIs shared across all tissues.
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Because the fold-change value is influenced by the number of clus-
ters (more clusters results in fewer co-clustered pairs), we used the same
number (k = 12) of clusters for all compared methods (Section 3.6).
4 Results
4.1 Independent clustering of multi-tissue data
does not capture biological information shared across
tissues
To study the necessity of dedicated multi-tissue clustering algorithms, we
analyzed 612 samples from 7 tissues from 121 individuals in the STock-
holm Atherosclerosis Gene Expression (STAGE) study [28, 17, 52]. We
clustered data from each tissue independently using k-means and selected
k = 12 clusters for all our analyses, as this value was near the inflection
point of the elbow plots in all tissues as it is shown in Fig. 1. We then
tested all 12 clusters in all tissues for functional enrichment using (fine-
grained) GO and (coarse-grained) GOSlim categories. We found that an
important proportion of both GO and GOSlim enriched categories were
shared across pairs of tissues, but this value falls below 40% when we
compare more than 3 tissues (Fig. 2). Moreover, similarity heatmaps
(Fig. 3A-B) showed that the degree of shared enrichment between tissues
didn’t reflect the degree of overall expression similarity. The similarities
between tissues are also poorly reflected at the level of individual clusters.
In particular, the cluster assigments between even the most closely related
tissue pairs (AAW/IMA and SF/VF) did not show any clear pattern to
allow to map clusters identified in one tissue to clusters identified in other
tissues Fig. 3D.
4.2 Multi-tissue clustering with revamp produces
mappable clusters with tunable overlap levels
To identify co-expression clusters that reflect biological similarities and
differences across tissues more accurately, we developed a model-based
multi-tissue clustering algorithm revamp, and implemented it in the Lemon-
Tree software [8]. Revamp identifies a set of linked clusters, where clus-
ter m in one tissue corresponds to cluster m in any other tissue. Each
linked cluster is anchored on a core set of genes that are co-expressed
and shared across all tissues, with additional sets of genes that co-express
with the core set in a tissue-specific manner (see Approach and Methods).
Unlike other algorithms [55], revamp can model non-linear relationships
between genes and incorporate prior information on the expected simi-
larities between tissues. Revamp starts from an initial k-means clustering
based on all tissue samples (or a representative randomly selected subset),
and then updates the cluster assignments for each tissue independently
using a Bayesian model-based score that depends on two (sets of) hyper-
parameters. A reassignment threshold parameter is used to control the
reassignment of genes from one cluster to another in the greedy optimiza-
8
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Figure 1: Percentage of variance explained as a function of the number of clus-
ters (k = 2, 3, ...100) in the partitions obtained with k-means algorithm.
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Figure 2: Percentage of shared enriched GO terms between different number
of tissues for independent clustering and the proposed multi-tissue clustering
method.
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Figure 3: On the top, the correlation matrix of gene expression values between
tissues (A) and the matrix of shared GO enrichments between tissues obtained
with the clustering the tissues independently (B) and with our method revamp
(C). On the bottom, percentage of genes that are present in the same cluster
both vascular (AAW, IMA) and adipose (SF, VF) tissues after clustering tissues
independently (D).
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Figure 4: On the left, average percentage of genes that overlap in each cluster
as function of the reassignment parameter. On the right, Venn diagram that
compares the set of genes in one cluster for AAW and IMA using two threshold
parameters  =0.001 (top) and  =0.005 (bottom).
tion algorithm, by only accepting such reassignments if they increase the
Bayesian score by more than the threshold value. A set of tissue similarity
parameters with values between zero and one is used to control the degree
of influence of expression data from one tissue on the cluster reassignment
in another tissue.
To test the influence of these parameters on the clustering outcome,
we again used k = 12 for the initial k-means clustering and systematically
tested (Fig. 4) a large space of parameter combinations for the subsequent
optimization algorithm. Both the reassignment threshold and tissue simi-
larities ultimately govern the degree of overlap across tissues of the linked
clusters, with small thresholds and near-zero similarities leading to nearly
tissue-independent clusterings, and large thresholds and/or near-one sim-
ilarities leading to nearly identical clusterings. Although the reassignment
and prior tissue similarity parameters are to some extent interchangeable
(i.e. a smaller threshold value can be compensated by a uniform increase in
similarity values), setting the reassignment threshold to a small, non-zero
value is recommended to avoid spurious reassignments due to numerical
round-off errors in the Bayesian score calculation.
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4.3 Revampmulti-tissue clustering is more enriched
for tissue protein–protein interactions than other
approaches
To evaluate the performance of revamp, we ran four multi-tissue cluster-
ing methods: revamp with prior tissue similarities set according to their
overall gene expression similarity, revamp with prior tissue similarities set
to zero, single-tissue clustering on vertically concatenated data, i.e. on
(gene,tissue)-by-individual data, and single-tissue clustering on horizon-
tally concatenated data, i.e. on gene-by-sample data, where each sample is
from a particular individual in a particular tissue, see Methods for details.
For each method, we tested for enrichment of human tissue protein-protein
interactions (PPIs) from the TissueNet database [6] among co-clustered
genes, using six tissues that matched between STAGE and TissueNet (see
Methods).
On a tissue-by-tissue basis, running revamp with or without prior tissue
similarity values resulted in similar fold-change enrichment values for tis-
sue PPIs (average fold-change over 6 tissues of 1.49 and 1.48, respectively)
as running single-tissue clustering on all 612 STAGE samples together (av-
erage fold-change 1.50), and considerably higher enrichment than using
vertically concatenated data (average fold-change 1.22) (Fig. 5). For a
baseline reference, we also calculated enrichment for each tissue clustered
individually using the single-tissue clustering method. Consistent with
the assumption that analyzing data integratively using multi-tissue clus-
tering should improve biological relevance, single-tissue clustering resulted
in lower fold-change values (average fold-change 1.31) (Fig. 5).
We further reasoned that genes assigned consistently to the same clus-
ter across all tissues (‘core’ cluster genes) should reflect tissue-independent
interactions between these genes. To test this hypothesis, we calculated
enrichment of tissue-independent PPIs (i.e. PPIs present in all six tissue
PPI networks) among core cluster genes. For revamp with prior tissue sim-
ilarity values, a significant increase in enrichment for tissue-independent
PPIs was observed (fold-change 1.72), whereas for revamp without prior
tissue similarities and horizontal data concatenation no difference was
observed compared to all tissue PPIs (fold-changes 1.47 and 1.57, respec-
tively) (Fig. 5). Vertical data concatenation resulted in very small core
gene sets, containing no known tissue-independent PPIs.
4.4 Functional predictions by Revamp clusters and
gene regulators associated with CAD
To test whether the clustering algorithm accurately captures the higher-
level biological process represented by each module, or set of processes, we
first performed gene ontology enrichment (Lemon-Tree task go annotation)
using the GO Slim ontology. Most significant enrichments are summarized
in Table 1. Network analysis revealed three connected components: clus-
ters 5, 9 and 10 were related with immune system response; the lipid
metabolic process was enriched in clusters 4, 6 and 7; and clusters 0 and 8
were associated with cell adhesion and extracellular matrix organization.
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Figure 5: Fold-change enrichment of tissue PPIs in tissue clusters for four multi-
tissue clustering methods. RW4 – revamp with prior tissue similarities set ac-
cording to their overall expression correlation, RA – revamp with prior tissue
similarities set to zero, VERT – vertical data concatenation, HORIZ – horizontal
data concatenation, INDIV – each tissue clustered individually. Each colored
bar shows the fold-change overlap of tissue PPIs in clusters for the matching
tissue; the black bar shows the fold-change overlap of tissue-shared PPIs in
tissue-shared genes of linked clusters. See Methods for details.
GO term cluster p-val range
immune system process 5,9,10 1.04E-19 – 3.00E-5
signal transduction 9 1.28E-2 – 3.82E-2
macromolecular complex assembly 10 1.13E-2 – 4.88E-2
carbohydrate metabolic process 10 1.40E-2 – 3.82E-2
protein complex assembly 10 1.22E-2 – 4.88E-2
cellular component assembly 10 1.22E-2 – 4.88E-2
lipid metabolic process 4,6,7 6.26E-4 – 1.89E-2
transmembrane transport 6 2.98E-3 – 2.98E-3
cell adhesion 0,8 2.54E-9 – 9.57E-5
extracellular matrix organization 0,8 6.24E-5 – 1.84E-2
cell proliferation 0 2.73E-3 – 2.54E-2
cell-cell signaling 8 2.95E-3 – 3.33E-2
Table 1: GO functional enrichment using GOSlim ontology. The terms pre-
sented are associated with all seven STAGE tissues.
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Figure 6: Module regulatory network for all 7 tissues. Only the regulators with
a score greater than 20 in the regulators task are represented, and we named
those with a score above 60. Regulators are presented as squares and clusters
as circles with size proportional to the number of genes in the cluster. Edges
are coloured per tissue as per Fig. 7, and their width is proportional to the
regulator score.
Then we ran independently on each tissue for each cluster the reg-
ulator probabilistic scoring task (Lemon-Tree task regulators) to pre-
dict upstream regulatory genes, considering as candidate regulators the
tissue-specific genes with genetic variants in their regulatory regions af-
fecting gene expression (“cis-eQTL effects”) in the STAGE individuals
[17] . The regulatory network of the most significant regulators for the
inferred modules is depicted in Fig. 6.
The development of atherosclerosis is in large part mediated by the
inflammatory cascade [11]. Our results indicated that the inflammatory
response in AAW may be regulated by PTAFR, a mediator in platelet
aggregation and the inflammatory response [42, 45]. SF and VF were
shown to be regulated by SIGLEC10 and CD247, respectively, genes that
have been previously associated with CAD [3, 47]. Other tissues were
linked to the previously identified inflammatory regulators BIN2 [38], CD2
[29], RAC2, that also directs plaque osteogenesis [9], and the pro-apoptotic
regulator of RAS protein, RASSF5 [12].
Lipid metabolism also plays a key role in the development of atheroma
plaques. Metabolism-related clusters 6 and 7 were found to be regulated
by genes AGXT2 and SPP2, in SF and VF respectively. AGXT2 polymor-
phisms were identified as risk for CAD in Asian populations [59, 57], and
SPP2 may contribute to the atheroprotective effects of HDL [1]. These
clusters may also be regulated by AADAC in SM, that controls the ex-
port of sterols [53]. In WB, we found MASP1, a gene associated with a
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decreased lectin pathway activity in acute myocardial infarction patients
[56].
The atherogenic pathway involves the inflammation of the arterial wall,
the injury of the intima, lipid infiltration and the activation of the angio-
genic signaling, processes that involve a dysfunction in the cell adhesion
[51]. Our analysis showed that RAB31, which induces lipid accumulation
in atheroma plaques [22], regulates the morphogenesis-related clusters 3
and 8 in SM. Cluster 3 was also shown to be regulated by CACNA1C
in SF, a gene involved in calcium channels and associated with inherited
cardiac arrhythmia [33], and COL18A1 in VF, that may control angiogen-
esis and vascular permeability [41]. The expression levels of the potential
regulators PCDH7, gene involved in cell adhesion, and TUBA1 were pre-
viously correlated with the extent of CAD [16, 49, 10].
4.5 Revamp discovers multi-tissue clusters under-
lying CAD phenotypes
The systems genetics paradigm says that genetic variants in regulatory
regions affect nearby gene expression (“cis-eQTL effects”), which then
causes variation in downstream gene networks (“trans-eQTL effects”) and
clinical phenotypes. We therefore used regression analysis to identify asso-
ciations between module gene expression and CAD phenotypes (see [52]),
as presented in Fig. 7.
The aggregated results revealed that AAW and SF are the main tis-
sues associated with very-low-density lipoprotein (VLDL) and low-density
lipoprotein (LDL) cholesterol levels, while the liver was the main tissue
associated with high-density lipoprotein (HDL) cholesterol. Besides that,
IMA was found to be associated in cluster 3 with the thyroid-stimulating
hormone, that causes many hemodynamic effects and influences the struc-
ture of the heart and circulatory system [24], and alcohol consumption in
clusters 5 and 9, whose associations with cardiovascular diseases are het-
erogeneous [7].
On the other hand, the results showed that the phenotypes related
to anthropometric measurements are mostly associated with SM, liver
and IMA, and with less significance with WB and AAW but they are
not correlated with the SF and VF. If we focus on clusters related to
body weight, as a typical example of a trait regulated by, and affecting
multiple tissues, we can find gene regulators such as PTAFR (in AAW)
and CD2 (in IMA) which have been described to affect food intake and
body weight, apart from the inflammatory response [37, 5]. In SM, RAC31
may influence on the body weight by mediating the insulin-stimulated
glucose uptake [40]. Last, also the candidate regulators BIN2 and RAC2
have been associated with obesity and metabolic syndrome [2, 58].
5 Conclusion
Herein we proposed a Bayesian model-based multi-tissue clustering al-
gorithm, revamp, which incorporates prior information on physiological
tissue similarity, and which results in a set of clusters consisting of a core
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Figure 7: Network representation of the correlation between the eigengenes,
the first principal component of a given module, and relevant CAD phenotypes
(squares), aggregated per tissue (circles). Edge width is inversely proportional
to the correlation p-value.
set of genes conserved across tissues as well as differential sets of genes spe-
cific to one or more subsets of tissues. Using data from seven vascular and
metabolic tissues from over 100 individuals in the STockholm Atheroscle-
rosis Gene Expression (STAGE) study, we demonstrated that our method
resulted in multi-tissue clusters with higher enrichment of tissue-specific
protein-protein interactions than comparable clustering algorithms. The
multi-tissue clusters inferred from the STAGE data highlighted the abil-
ity of revamp to link together regulatory genes, biological processes and
clinical patient characteristics in a meaningful way across multiple tis-
sues, and we believe this makes it an attractive and statistically sound
method for analyzing multi-tissue gene expression datatsets in general.
Revamp is implemented and freely available in the Lemon-Tree software,
at https://github.com/eb00/lemon-tree.
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